knowledge -WSS

knowledge

author：hotspot 2025-09-06 04:15:06 - browse：2

Today, if you want to know what scary family health secrets lay buried in your DNA or get screened for a lurking cancer, you have a lot of options. Laboratories have developed more than 75,000 genetic tests, with about 10 new ones entering the market daily. By the end of 2019, more than 26 million Americans had had their DNA decoded to some degree or another. Since then, that number has surely grown.

But this testing frenzy would have been inconceivable just 10 years ago. In part, that’s because the technology back then was so expensive. More importantly, until 2013, it was common practice for gene-hunting academics and companies to lock up their discoveries with DNA patents, effectively carving up the human genome into mini-monopolies. That year, the U.S. Supreme Court threw a bomb into the biotech world when it took up a landmark case that pitted cancer survivors and the American Civil Liberties Union against a diagnostics company called Myriad Genetics, which had obtained exclusive patents on the cancer-causing BRCA genes and made billions of dollars selling tests for them.

A new book called “The Genome Defense,” written by University of Utah science and technology law expert Jorge Contreras and being published Oct. 26, provides a front-row seat to the courtroom drama that would upend three decades of federal intellectual property law and chart a new course toward balancing corporate profits with the rights of all people to the information written into their DNA.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： ER docs worry over extreme heat as a 'mass casualty event'

Wikipedia

WSS

Lab trade group sues FDA to halt regulation of lab

Average age of first period drops to 11.9 years, study shows

Flagship, Pfizer team up in deal worth up to $7 billion

Average age of first period drops to 11.9 years, study shows

Report: NIH

Adam's Biotech Scorecard: Do Sarepta's exon

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Flagship, Pfizer team up in deal worth up to $7 billion

Walensky prepares to leave CDC — and Congress — behind

Startling documents reveal new facets of Sacklers' opioid empire

Peter Hotez and the public health issue of online harassment

Why you get paid to donate plasma but not blood

Hepatitis C has a cure — but many Americans still lack access to it

Childbirth

The high cost of giving birth even with insurance

Scientists successfully use ultrasound imaging to map brain activity

hotspot

Prosthetic arm enables patients to feel the objects they grip

Prosthetic arm enables patients to feel the objects they grip

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

15 die by electrocution after transformer explodes in northern India

Antibiotic resistance nearly killed me, so I'm raising awareness of it

ER docs worry over extreme heat as a 'mass casualty event'

Wikipedia

explore

Wikipedia

leisure time